Fredag 30 Oktober | 04:06:20 Europe / Stockholm
Est. tid*
2027-10-29 21:05 Kvartalsrapport 2027-Q3
2027-07-29 21:05 Kvartalsrapport 2027-Q2
2027-04-29 21:05 Kvartalsrapport 2027-Q1
2027-01-28 N/A Bokslutskommuniké 2026
2026-10-29 - Kvartalsrapport 2026-Q3
2026-09-30 - X-dag kvartalsutdelning SYK 0.88
2026-07-30 - Kvartalsrapport 2026-Q2
2026-06-30 - X-dag kvartalsutdelning SYK 0.88
2026-05-06 - Årsstämma
2026-04-30 - Kvartalsrapport 2026-Q1
2026-03-31 - X-dag kvartalsutdelning SYK 0.88
2026-01-29 - Bokslutskommuniké 2025
2025-12-31 - X-dag kvartalsutdelning SYK 0.88
2025-10-30 - Kvartalsrapport 2025-Q3
2025-09-30 - X-dag kvartalsutdelning SYK 0.84
2025-07-31 - Kvartalsrapport 2025-Q2
2025-06-30 - X-dag kvartalsutdelning SYK 0.84
2025-05-08 - Årsstämma
2025-05-01 - Kvartalsrapport 2025-Q1
2025-03-31 - X-dag kvartalsutdelning SYK 0.84
2025-01-28 - Bokslutskommuniké 2024
2024-12-31 - X-dag kvartalsutdelning SYK 0.84
2024-10-29 - Kvartalsrapport 2024-Q3
2024-09-30 - X-dag kvartalsutdelning SYK 0.8
2024-07-30 - Kvartalsrapport 2024-Q2
2024-06-28 - X-dag kvartalsutdelning SYK 0.8
2024-05-09 - Årsstämma
2024-04-30 - Kvartalsrapport 2024-Q1
2024-03-28 - X-dag kvartalsutdelning SYK 0.8
2024-01-30 - Bokslutskommuniké 2023
2023-12-28 - X-dag kvartalsutdelning SYK 0.8
2023-11-02 - Kvartalsrapport 2023-Q3
2023-09-28 - X-dag kvartalsutdelning SYK 0.75
2023-08-03 - Kvartalsrapport 2023-Q2
2023-06-29 - X-dag kvartalsutdelning SYK 0.75
2023-05-10 - Årsstämma
2023-05-01 - Kvartalsrapport 2023-Q1
2023-03-30 - X-dag kvartalsutdelning SYK 0.75
2023-01-31 - Bokslutskommuniké 2022
2022-12-29 - X-dag kvartalsutdelning SYK 0.75
2022-10-31 - Kvartalsrapport 2022-Q3
2022-09-29 - X-dag kvartalsutdelning SYK 0.695
2022-07-26 - Kvartalsrapport 2022-Q2
2022-06-29 - X-dag kvartalsutdelning SYK 0.695
2022-05-04 - Årsstämma
2022-04-28 - Kvartalsrapport 2022-Q1
2022-03-30 - X-dag kvartalsutdelning SYK 0.695
2021-12-30 - X-dag kvartalsutdelning SYK 0.695
2021-10-28 - Kvartalsrapport 2021-Q3
2021-09-29 - X-dag kvartalsutdelning SYK 0.63
2021-07-27 - Kvartalsrapport 2021-Q2
2021-06-29 - X-dag kvartalsutdelning SYK 0.63
2021-05-06 - Årsstämma
2021-04-27 - Kvartalsrapport 2021-Q1
2021-03-30 - X-dag kvartalsutdelning SYK 0.63
2021-01-27 - Bokslutskommuniké 2020
2020-12-30 - X-dag kvartalsutdelning SYK 0.63
2020-10-29 - Kvartalsrapport 2020-Q3
2020-09-29 - X-dag kvartalsutdelning SYK 0.575
2020-07-30 - Kvartalsrapport 2020-Q2
2020-06-29 - X-dag kvartalsutdelning SYK 0.575
2020-05-05 - Årsstämma
2020-04-30 - Kvartalsrapport 2020-Q1
2020-03-30 - X-dag kvartalsutdelning SYK 0.575
2020-01-28 - Bokslutskommuniké 2019
2019-12-30 - X-dag kvartalsutdelning SYK 0.575
2019-09-27 - X-dag kvartalsutdelning SYK 0.52
2019-07-23 - Kvartalsrapport 2019-Q2
2019-04-23 - Kvartalsrapport 2019-Q1
LandUSA
Lista70
SektorHälsovård
IndustriMedicinteknik
Stryker är verksamt inom medicinteknik. Bolaget erbjuder produkter och tjänster inom ortopedi, samt medicinsk - och kirurgisk terapibehandling. Bolagets produktutbuded inkluderar utrustning för akutmottagningar, kirurgisk utrustning samt endoskopiska system. Strykers verksamhet innehas på global nivå. Bolaget grundades år 1946 och har huvudkontor i Kalamazoo.

All ägardata du vill ha finns i Holdings!

Stryker announces intention to nominate Manny Maceda to board of directors

2025-03-26 15:15:00

Portage, Michigan, March 26, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its board of directors has nominated Emmanuel “Manny” Maceda for election to the company’s board at the 2025 Annual Meeting of Shareholders, scheduled for May 8, 2025.

Manny brings more than 30 years of experience leading high-performing organizations and advising senior executives on large-scale corporate transformations. He currently serves as Chairman of Bain & Company, following his tenure as Worldwide Managing Partner and CEO from 2018 to 2024. In that role, he led Bain’s global strategy and operations across more than 50 offices, driving the firm’s transformation to strengthen digital capabilities, expand its focus on sustainability, and preserve its award-winning culture.

Since joining Bain in 1989, Maceda has held multiple senior leadership roles and advised CEOs across a wide range of industries on enterprise-wide initiatives spanning strategy, growth, cost management, and organizational effectiveness.

He holds a Master of Science in Management from the MIT Sloan School of Management where he serves on the advisory board, and a bachelor’s degree in chemical engineering, with High Honors, from the Illinois Institute of Technology.

“We look forward to the potential of adding Manny to our Board,” said Kevin Lobo, Chair and CEO, Stryker. “His strategic acumen, global leadership experience and track record in transformation will enhance the Board as we grow, evolve and create long-term value for shareholders.”

About Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

Contacts

For investor inquiries:
Jason Beach, Vice President, Investor Relations at 269-385-2600 or jason.beach@stryker.com 

For media inquiries:
Kim Montagnino, Vice President, Global Communications at 269-385-2600
or kim.montagnino@stryker.com